Hosted on MSN11m
Moderna Stock Down 39% in Three Months: Buy the Dip or Wait?
Despite being a pioneer in developing one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have ...
BMJ4h
FDA pauses all infant RSV vaccine trials after rise in severe illnesses
The US Food and Drug Administration (FDA) has put on hold all respiratory syncytial virus (RSV) vaccine trials involving infants (aged under 2 years) or RSV naive children aged 2-5 years, after a ...
Bivalent vaccines looking unlikely
Chances of Malaysians getting their hands on updated Covid-19 vaccines appear dim following what appears to be a lack of ...